Sign in Register

Daunorubicin (daunorubicin HCl)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: Daunorubicin is used to treat leukemia and other cancers. It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells.

Generic name: daunorubicin HCl
Pronunciation: (dawn-oh-REWB-eh-sin)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Daunorubicin

Intelligence content is not available yet.

Indications

The following indications are listed for Daunorubicin:

  • Acute Lymphoid Leukemia
  • Acute Monocytic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Erythroid Leukemia

Also known as: Acute Granulocytic Leukemia, Acute Leukemic Myelosis, Acute Lymphatic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphogenous Leukemia, Acute Myelocytic Leukemia, Acute Myelogenic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, M6 Type, Acute Non-Lymphoblastic Leukemia, Acute Non-Lymphocytic Leukemia, Erythremic Myelosis, Erythroleukemia, Lymphoblastic Leukemia, Monocytic Leukemia, Promyelocytic Leukemia, Schilling's Leukemia.

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data